Patents Assigned to TOPFOND PHARMACEUTICAL CO., LTD.
  • Application of naringenin and naringin in tumor radiotherapy
    Patent number: 10307393
    Abstract: The present invention provides applications of a small molecular flavonoid compound in preparing a medication for sensitizing/synergizing tumor radiation therapy as well as reducing radioactive damage. The small molecular flavonoid compound can be naringenin, hesperetin, luteolin and apigenin, etc. The medication contains a small molecular flavonoid compound and a plurality of conventional pharmaceutical additives; wherein the small molecular flavonoid compound is an active ingredient.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: June 4, 2019
    Assignees: INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES, TOPFOND PHARMACEUTICAL CO., LTD.
    Inventors: Wei Liang, Chun Ling Zhang, Wen Feng Zeng, Chao Zhang, Luo Yang Wang